-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

623A.O2.6 623. Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Prospective and Real-World Outcomes of Novel Therapies in Indolent Lymphomas and MCL

Symposia: Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Lymphomas, non-Hodgkin lymphoma, B Cell lymphoma, Diseases, indolent lymphoma, aggressive lymphoma, Lymphoid Malignancies
Saturday, December 9, 2023: 4:00 PM-5:30 PM
Seaport Ballroom ABCD (Manchester Grand Hyatt San Diego)
Moderators:
Carla Casulo, MD, James P. Wilmot Cancer Center and Swetha Kambhampati, MD, City of Hope Comprehensive Cancer Center
Disclosures:
Casulo: Genentech: Consultancy, Research Funding; GenMab: Research Funding; Gilead Sciences: Research Funding; SecuraBio: Research Funding; Bristol Myers Squibb: Consultancy, Research Funding; Verastem: Research Funding; Abbvie: Consultancy; Follicular Lymphoma Foundation: Other: Leadership role; Lymphoma Research Foundation: Other: Leadership Role. Kambhampati: ADC Therapeutics: Research Funding; Genentech: Research Funding; Genmab: Research Funding.
This session contains abstracts that describe results of prospective trials in FL and Gastric MALT and real-world outcomes of novel agents in FL and MCL.
4:00 PM

Emanuele Zucca, MD1,2,3, Saemi Schaer4*, Anna Vanazzi, MD5*, Bjørn Østenstad, MD, PhD6*, Ulrich Mey, MD7, Daniel Rauch8*, Björn E. Wahlin, MD, PhD9, Felicitas Hitz10*, Micaela Hernberg11*, Ann-Sofie Johansson12*, Peter de Nully Brown, MD, PhD13, Hans Hagberg14*, Andrés José María Ferreri, MD15, Fatime Krasniqi, MD, PhD16*, Michèle Voegeli, MD17*, Urban Novak, MD18*, Thilo Zander19*, Hanne Bersvendsen20*, Christoph Mamot, M.D.21*, Walter Mingrone22*, Anastasios Stathis, MD23*, Stefan Dirnhofer24*, Stefanie Hayoz25* and Eva Kimby26*

1Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland
2Institute of Oncology Research (IOR), Bellinzona, Switzerland
3Division of Medical Oncology, Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale, Bellinzona, Switzerland
4Swiss Group For Clinical Cancer Research (SAKK), Bern, CHE
5Clinical Hemato-Oncology, Istituto Europeo di Oncologia IRCCS, Milano, Italy
6Department of Oncology, Oslo University Hospital, Oslo, Norway
7Oncology and Hematology, Cantonal Hospital Grisons, Chur, GR, Switzerland
8Division of Oncology, Spital Thun Simmenthal, Thun, Switzerland
9Karolinska Universitetssjukhuset Solna, Solna, Sweden
10Oncology/Hematology, Kantonsspital St.Gallen, St. Gallen, Switzerland
11Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
12Department of Oncology, Norrlands University Hospital Umeå, Umeå, Sweden
13Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
14Oncology, Uppsala University Hospital, Uppsala, Sweden
15Unit of Lymphoid Malignancies, Department of Onco-Haematology, IRCCS San Raffaele Scientific Institute, Milano, Italy
16Department of Oncology, University Hospital Basel, Basel, Switzerland
17Department of Hematology and Oncology, Kantonsspital Baselland, Liestal, Switzerland
18Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
19Department of Oncology, Luzerner Kantonsspital, Luzern 16, Switzerland
20Department of Oncology, University Hospital of North Norway, Tromsø, Norway
21Division of Hematology/Oncology, Kantonsspital Aarau, Aarau, Switzerland
22Department of Medical Oncology, Kantonsspital Olten, Olten, Switzerland
23Medical Oncology Clinic, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland
24Institute of Pathology, University Hospital Basel, Basel, Switzerland
25Swiss Group For Clinical Cancer Research (SAKK), Bern, Switzerland
26Division of Hematology, Department of Medicine at Huddinge, Karolinska Institutet, Stockholm, Sweden

4:15 PM

Loic Ysebaert, MD, PhD1*, Roch Houot, MD, PhD2*, Olivier Casasnovas, MD3*, Choquet Sylvain4*, Fabrice Jardin, MD PhD5*, Michael Loschi, MD6*, Gabriel Brisou7*, Catherine Thieblemont, MD8*, Jacques-Olivier Bay, MD, PhD9*, Cristina Castilla-Llorente, MD10*, Tom Fradon11*, Steven Le Gouill, MD, PhD12, Franck Morschhauser, phd13,14, Guillaume Cartron, MD, Ph-D15* and Emmanuel Bachy, MD, PhD16*

1Hematology Department, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
2Clinical Hematology, INSERM U1236, EFS, Hopital Pontchaillou, Rennes University Hospital, Rennes, France
3Clinical Hematology, François Mitterand Hospital, Dijon, FRA
4Hopital de la Pitié Salpetrière, APHP, Paris, FRA
5Centre Henri-Becquerel and University of Rouen, Rouen, France
6Service d’hématologie, CHU de Nice, Nice, France
7Institut Paoli-Calmettes, Department of Hematology, Marseille Cedex 09, France
8Assistance Publique Des Hopitaux De Paris, Paris, FRA
9Service d’hématologie, CHU Clermont-Ferrand, Clermont-Ferrand, France
10Department of Hematology, Gustave Roussy Cancer Campus, Villejuif, France
11LYSARC, Lyon, France
12Hematology Department, Institut Curie, Paris, France
13Hôpital Claude Huriez, Lille, France
14University of Lille, Lille, FRA
15Clinical Hematology Department, Montpellier University Hospital Center, Montpellier, France
16Lyon-Sud Hospital Center, Pierre-Bénite, France

4:30 PM

Loic Ysebaert, MD, PhD1*, Francois Lemonnier2*, Gabriel Brisou3*, Olivier Casasnovas, MD4*, Gian Matteo Pica, MD5*, Emmanuel Bachy, MD, PhD6*, Ludovic Fouillet, MD7*, Julie Abraham8*, Stephanie Guidez9*, Marc André, MD, PhD10*, Guillaume Cartron, MD, Ph-D11*, Romain Guieze, MD, PhD12*, Sylvain Carras13*, Benoit Tessoulin14*, Roch Houot, MD, PhD15*, Bohrane Slama16*, Christophe Bonnet, MD, PhD17*, Luc-Matthieu Fornecker, MD, PhD18*, Marie-Helene Delfau, MD PhD19*, Clementine Sarkozy20*, Camille Laurent, MD, PhD21*, Vincent Ribrag, MD22 and Franck Morschhauser, phd23

1Hematology Department, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
2Department of Hematology, Henri Mondor Hospital, Créteil, France
3Institut Paoli-Calmettes, Department of Hematology, Marseille Cedex 09, France
4Clinical Hematology, François Mitterand Hospital, Dijon, FRA
5Hematology department, CH Chambery, Chambery, France
6Hematology Department, Lyon Sud Hospital, Pierre-Bénite, France
7Hematology department, CHU, Saint-Etienne, France
8CHU DE LIMOGES - HÔPITAL UNIVERSITAIRE DUPUYTREN, Limoges, FRA
9CHU de Poitiers, Poitiers, France
10CHU UCL Namur, Yvoir, Belgium
11Centre Hospitalier Universitaire de Montpellier, Montpellier, France
12CHU Estaing, Clermont Ferrand, FRA
13Hematology, CHU GRENOBLE - HÔPITAL ALBERT MICHALLON, Grenoble, France
14Hematology Department, CHU Nantes, Nantes, France
15Clinical Hematology, INSERM U1236, EFS, Hopital Pontchaillou, Rennes University Hospital, Rennes, France
16Service d'onco-hématologie, Centre Hospitalier Général d'Avignon, Avignon, FRA
17Hematology Department, CHU Liège, Liège, Belgium
18Hematology Department, Institut De Cancérologie Strasbourg Europe, Strasbourg, France
19Departement d’Hematologie et Immunologie, AP-HP, Hopital Henri Mondor, Creteil, France
20Hematology departement, institut Curie, Paris, France
21Pathology Department, Institut Universitaire du Cancer , Oncopole, Toulouse, France
22Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP), Gustave Roussy Institute of Cancer,, Villejuif, France
23CHU de Lille, Lille, France

4:45 PM

Jillian Gunther, MD PhD1*, Jie Xu, MD PhD2*, Manoop S Bhutani, MD3*, Paolo Strati, MD4, Penny Fang, MD1*, Susan Wu, MD1*, Bouthaina S. Dabaja, MD1*, Wenli Dong5*, Priya Bhosale, MD6*, Christopher R. Flowers, MD, MS7, Ranjit Nair, MD8, Luis Malpica, MD7*, Preetesh Jain, MD, MBBS, PhD, DM7, Sattva S. Neelapu, MD4, Maria Alma Rodriguez, MD7*, Dai Chihara, MD, PhD4, Loretta J. Nastoupil, MD9 and Chelsea Camille Pinnix, MD, PhD1

1Radiation Oncology, MD Anderson Cancer Center, Houston, TX
2Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX
3Gastroenterology Hepatology & Nutrition, MD Anderson Cancer Center, Houston, TX
4Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
5Biostatistics, MD Anderson Cancer Center, Houston, TX
6Abdominal Imaging Department, MD Anderson Cancer Center, Houston, TX
7Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
8Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Pearland, TX
9MD Anderson Cancer Center, Houston, TX

5:00 PM

Clementine Sarkozy1*, Loïc Chartier2*, Vincent Ribrag3*, Remy Gressin, MD4*, Christian Geisler, MD, PhD5*, Hanneke Kluin-Nelemans6*, Catherine Thieblemont, MD7*, Franck Morschhauser, MD PhD8, Corinne Haioun, MD, PhD9, Violaine Safar, MD10*, Herve Ghesquieres, MD, PhD11*, Wolframm Klapper12*, Barbara Burroni, MD13*, Christiane Pott14*, Marie-Helene Delfau, MD PhD15*, Elizabeth A. Macintyre, MD, PhD16, Mary Callanan17*, Michael Unterhalt18*, Eva Hoster19*, Martin Dreyling, MD20, Steven Le Gouill, MD, PhD21, Olivier Hermine22* and Morgane Cheminant23*

1Hematology departement, institut Curie, Paris, France
2LYSARC, Pierre Bénite, France
3Institut Gustave Roussy, Villejuif, FRA
4HOPITAL ALBERT MICHALLON, Department of Hematology, University Hospital Grenoble, Grenoble, France
5Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
6University Medical Center Groningen, University of Groningen, Groningen, NLD
7Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Hemato-oncologie, Université de Paris, Paris, France
8CHRU de Lille, Hôpital Claude Huriez, Lille, Cedex, FRA
9Lymphoid Malignancies Department, Henri Mondor University Hospital, AP-HP, Créteil, France
10Hematology Department, Hôpital Lyon Sud - HCL, Lyon, France
11Hematology, Lyon, FRA
12University Hospital Schleswig-Holstein, Campus Kiel, Kiel, DEU
13Pathology, Cochin, Paris, FRA
14Second Medical Department, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
15Hemato-biology, Henri Mondor University Hospital, Créteil, France
16Laboratory of Onco-Hematology, Necker Enfants-Malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France, Paris, FRA
17INSERM U823, Grenoble, FRA
18University of Munich, Munich, DEU
19Institute of Medical Data Processing, Biometrics and Epidemiology (IBE), LMU Munich, Munich, Germany
20Department of Medicine, Medical Clinic III, Ludwig-Maximilians-University Hospital, Munich, Germany
21Hematology Department, Institut Curie, Paris, France
22Hematology Department, Necker University Hospital, Paris, France
23Department of Hematology, Necker Hospital, APHP, Paris, France

5:15 PM

Yucai Wang, MD, PhD1, Melissa C. Larson, MS2*, Steven R. Hwang, MD3, Anita Kumar, MD4, Ashlee Joseph5*, Brian T. Hill, MD6, Taylor R. Brooks, MD6*, David A. Bond, MD, BS7, Kami J. Maddocks, MD8, Alexey Danilov, MD9, Christine McCarthy, BS9*, Jia Ruan, MD, PhD10, Imran A. Nizamuddin, MD11, Brad S. Kahl, MD12, Natalie S. Grover, MD13, Nazneen B. Khan13*, Evguenia Ouchveridze, MD14, Aung M. Tun, MD15, Philip Young, MD16*, Craig A. Portell, MD16, Zoey I. Harris, MD17*, Javier L. Munoz18, Patrick M. Reagan, MD19, Georgio Pongas, MD20*, Izidore S. Lossos, MD20, Christine E. Ryan, MD21, Reid W. Merryman, MD21, Firas Baidoun, MD22, Muhamad Alhaj Moustafa, MD22, Drew Gerber, BS23, Sabarish R. Ayyappan, MD24, Brian K. Link, MD25*, Arash Velayati, MD26*, Irl Brian Greenwell, MD26, Lauren G Banaszak, MD27, Priyanka A Pophali, MD28, Anthony C. Stack, DO29*, Marcus R. Messmer, MD29, Mayur Narkhede, MD30*, Amitkumar N. Mehta, MD31, Preetesh Jain, MD, MBBS, PhD, DM32, Michael L. Wang, MD33, Tamara K. Moyo, MD34*, Nilanjan Ghosh, MD, PhD35, Rahul S. Bhansali, MD36, Stefan K. Barta, MD37, Manali K. Kamdar, MD, MBBS38, Jacob Anna39*, Alexander V. Stanisic, MD40*, Reem Karmali, MD, MSc40, Laveniya Kugathasan41*, Diego Villa, MD42, Matthew J. Maurer, DSc3, James R. Cerhan, MD, PhD43, Jonathon B. Cohen, MD, MS23 and Peter Martin, MD10

1Division of Hematology, Mayo Clinic, Rochester, MN
2Division of Epidemiology, Mayo Clinic, Rochester, MN
3Mayo Clinic, Rochester, MN
4Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Short Hills, NJ
5Memorial Sloan Kettering Cancer Center, New York
6Cleveland Clinic, Cleveland, OH
7The James Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH
8The James Cancer Center, Ohio State University Hospital, Columbus, OH
9City of Hope National Medical Center, Duarte, CA
10Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY
11Washington University in St. Louis, St Louis, MO
12School of Medicine, Washington University in St. Louis, St Louis, MO
13The University of North Carolina at Chapel Hill, Chapel Hill, NC
14Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas, Kansas City, KS
15The University of Kansas Cancer Center, Kansas City, KS
16University of Virginia, Charlottesville, VA
17Mayo Clinic, Phoenix, AZ
18Department of Hematology, Mayo Clinic, Phoenix, AZ
19University of Rochester Medical Center, Rochester, NY
20University of Miami, Miami, FL
21Dana-Farber Cancer Institute, Boston, MA
22Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
23Emory University, Atlanta, GA
24University of Iowa, newnan, GA
25University of Iowa, Iowa City, IA
26Medical University of South Carolina, Charleston, SC
27Division of Hematology, Medical Oncology, and Palliative Care, Department of Medicine, University of Wisconsin-Madison, Madison, WI
28University of Wisconsin-Madison, Madison, WI
29Fox Chase Cancer Center, Philadelphia, PA
30University of Alabama at Birmingham, Birmingham, AL
31University of Alabama At Birmingham, Birmingham, AL
32The University of Texas MD Anderson, Houston, TX
33University of Texas MD Anderson Cancer Center, Houston, TX
34Atrium Health / Levine Cancer Institute, Charlotte, NC
35Atrium Health Levine Cancer Institute, Charlotte, NC
36Department of Medicine, Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
37Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
38University of Colorado, Denver, CO
39University of Colorado, Aurora, CO
40Northwestern University, Chicago, IL
41BC Cancer, Vancouver, BC, Canada
42Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
43Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN

*signifies non-member of ASH